British Journal of Clinical Pharmacology, 87(3), 1129-1140. Wiley-Blackwell Morales, D R, Morant, S V, MacDonald, T M, Hallas, J, Ernst, M T, Pottegard, A, Herings, R M C, Smits, E, Overbeek, J A, Mackenzie, I S, Doney, A S F, Mitchell, L, Bennie, M, Robertson, C, Wei, L, Nicholson, L, Morris, C & Flynn, R W V 2021, ' Impact of EU regulatory label changes for diclofenac in people with cardiovascular disease in four countries : Interrupted time series regression analysis ', British Journal of Clinical Pharmacology, vol. 87, no. 3, pp. 1129-1140 . https://doi.org/10.1111/bcp.14478
Pharmacoepidemiology and Drug Safety, 29(3), 296-305. John Wiley and Sons Ltd Pharmacoepidemiology and Drug Safety Morales, D R, Morant, S V, MacDonald, T M, Mackenzie, I S, Doney, A S F, Mitchell, L, Bennie, M, Robertson, C, Hallas, J, Pottegard, A, Ernst, M T, Wei, L, Nicholson, L, Morris, C, Herings, R M C, Overbeek, J A, Smits, E & Flynn, R W V 2020, ' Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands ', Pharmacoepidemiology and Drug Safety, vol. 29, no. 3, pp. 296-305 . https://doi.org/10.1002/pds.4955 Morales, D R, Morant, S V, MacDonald, T M, Mackenzie, I S, Doney, A S F, Mitchell, L, Bennie, M, Robertson, C, Hallas, J, Pottegard, A, Ernst, M T, Wei, L, Nicholson, L, Morris, C, Ron, M C, Overbeek, J A, Smits, E & Robert, W V 2020, ' Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands ', Pharmacoepidemiology and Drug Safety, vol. 29, no. 3, pp. 296-305 . https://doi.org/10.1002/pds.4955